To gain a clearer understanding of the differences between childhood cancer patients when it comes to the impact of radiation therapy on cognition, scientists at St. Jude Children's Research Hospital studied the effect of ...
Apr 28, 2023
0
25
A study conducted by Mayo Clinic suggests artificial intelligence could potentially improve time efficiency and standardization for radiation therapy planning in patients with head and neck cancers. The validation study, ...
Apr 27, 2023
0
6
A unique treatment combining radiation and immunotherapy can eradicate pancreatic tumors while stopping the cancer from spreading, according to a new study by researchers at the University of Colorado Cancer Center.
Apr 27, 2023
0
80
Little is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors. But a study out of Roswell Park Comprehensive Cancer Center is shedding light on that process, ...
Apr 25, 2023
0
2
A new clinical guideline from the American Society for Radiation Oncology (ASTRO) and European Society for Radiotherapy & Oncology (ESTRO) provides guidance on the use of definitive local therapy—including radiation and ...
Apr 25, 2023
0
15
The first in-human-study of a new immunotherapy that blocks a natural enzyme tumors commandeer for their protection was well tolerated by children with relapsed brain tumors and enabled many to have unexpected months of a ...
Apr 25, 2023
0
9
April is Head and Neck Cancer Awareness Month, which makes this a good time to learn about three types of cancer that affect these areas of the body.
Apr 21, 2023
0
2
St. Jude Children's Research Hospital is reporting phase 2 clinical trial results treating the brain tumor craniopharyngioma with proton therapy. The researchers found a similar survival rate between more targeted proton ...
Apr 19, 2023
0
46
Data from a national clinical trial shows that a striking 89% of patients with desmoplastic melanoma responded to immunotherapy (pembrolizumab) alone, suggesting that many patients could avoid the risk for toxicity from combination ...
Apr 17, 2023
0
2
Repeat radiation therapy combined with the monoclonal antibody drug bevacizumab extended progression-free survival in patients with recurrent glioblastoma, according to findings from a recent clinical trial published in the ...
Apr 10, 2023
0
21
